308 related articles for article (PubMed ID: 32742126)
61. Maintenance of Gastrointestinal Glucose Homeostasis by the Gut-Brain Axis.
Chen X; Eslamfam S; Fang L; Qiao S; Ma X
Curr Protein Pept Sci; 2017; 18(6):541-547. PubMed ID: 27356933
[TBL] [Abstract][Full Text] [Related]
62. Mixed Meal and Intravenous L-Arginine Tests Both Stimulate Incretin Release Across Glucose Tolerance in Man: Lack of Correlation with β Cell Function.
Ruetten H; Gebauer M; Raymond RH; Calle RA; Cobelli C; Ghosh A; Robertson RP; Shankar SS; Staten MA; Stefanovski D; Vella A; Wright K; Fryburg DA;
Metab Syndr Relat Disord; 2018 Oct; 16(8):406-415. PubMed ID: 30117761
[TBL] [Abstract][Full Text] [Related]
63. The Potential Role of Yogurt in Weight Management and Prevention of Type 2 Diabetes.
Panahi S; Tremblay A
J Am Coll Nutr; 2016; 35(8):717-731. PubMed ID: 27332081
[TBL] [Abstract][Full Text] [Related]
64. Gut sweet taste receptors and their role in metabolism.
Meyer-Gerspach AC; Wölnerhanssen B; Beglinger C
Front Horm Res; 2014; 42():123-33. PubMed ID: 24732930
[TBL] [Abstract][Full Text] [Related]
65. Mechanisms Underlying Gut Hormone Secretion Using the Isolated Perfused Rat Small Intestine.
Kuhre RE; Holst JJ
J Vis Exp; 2019 Feb; (144):. PubMed ID: 30882791
[TBL] [Abstract][Full Text] [Related]
66. Gut microbiota, enteroendocrine functions and metabolism.
Cani PD; Everard A; Duparc T
Curr Opin Pharmacol; 2013 Dec; 13(6):935-40. PubMed ID: 24075718
[TBL] [Abstract][Full Text] [Related]
67. [New approaches in obesity treatment: the gastrointestinal tract as an endocrine organ].
Silveira Rodríguez MB; Gómez-Pan A; Carraro Casieri R
Med Clin (Barc); 2006 Sep; 127(8):300-5. PubMed ID: 16949016
[TBL] [Abstract][Full Text] [Related]
68. From Entero-Endocrine Cell Biology to Surgical Interventional Therapies for Type 2 Diabetes.
Guimarães M; Pereira SS; Monteiro MP
Adv Exp Med Biol; 2021; 1307():273-297. PubMed ID: 32016913
[TBL] [Abstract][Full Text] [Related]
69. Role of gastrointestinal hormones in feeding behavior and obesity treatment.
Kairupan TS; Amitani H; Cheng KC; Runtuwene J; Asakawa A; Inui A
J Gastroenterol; 2016 Feb; 51(2):93-103. PubMed ID: 26346735
[TBL] [Abstract][Full Text] [Related]
70. Obesity-related gut hormones and cancer: novel insight into the pathophysiology.
Guzzardi MA; Pugliese G; Bottiglieri F; Pelosini C; Muscogiuri G; Barrea L; Savastano S; Colao A
Int J Obes (Lond); 2021 Sep; 45(9):1886-1898. PubMed ID: 34088971
[TBL] [Abstract][Full Text] [Related]
71. Enteroendocrine hormone mimetics for the treatment of obesity and diabetes.
Irwin N; Flatt PR
Curr Opin Pharmacol; 2013 Dec; 13(6):989-95. PubMed ID: 24064397
[TBL] [Abstract][Full Text] [Related]
72. Gut: A key player in the pathogenesis of type 2 diabetes?
Muscogiuri G; Balercia G; Barrea L; Cignarelli A; Giorgino F; Holst JJ; Laudisio D; Orio F; Tirabassi G; Colao A
Crit Rev Food Sci Nutr; 2018 May; 58(8):1294-1309. PubMed ID: 27892685
[TBL] [Abstract][Full Text] [Related]
73. Contribution of the distal small intestine to metabolic improvement after bariatric/metabolic surgery: Lessons from ileal transposition surgery.
Oh TJ; Ahn CH; Cho YM
J Diabetes Investig; 2016 Apr; 7 Suppl 1(Suppl 1):94-101. PubMed ID: 27186363
[TBL] [Abstract][Full Text] [Related]
74. The Changing Concept of Gut Endocrinology.
Rehfeld JF
Endocr Dev; 2017; 32():8-19. PubMed ID: 28873381
[TBL] [Abstract][Full Text] [Related]
75. Gastrointestinal peptides--rôle in pathophysiology and disease.
Creutzfeldt W
Scand J Gastroenterol Suppl; 1982; 77():7-20. PubMed ID: 6750831
[TBL] [Abstract][Full Text] [Related]
76. The gut-brain axis in obesity.
Buhmann H; le Roux CW; Bueter M
Best Pract Res Clin Gastroenterol; 2014 Aug; 28(4):559-71. PubMed ID: 25194175
[TBL] [Abstract][Full Text] [Related]
77. Luminal Chemosensory Cells in the Small Intestine.
Burman A; Kaji I
Nutrients; 2021 Oct; 13(11):. PubMed ID: 34835968
[TBL] [Abstract][Full Text] [Related]
78. Gastrointestinal regulation of food intake.
Cummings DE; Overduin J
J Clin Invest; 2007 Jan; 117(1):13-23. PubMed ID: 17200702
[TBL] [Abstract][Full Text] [Related]
79. In Vivo Models for Incretin Research: From the Intestine to the Whole Body.
Oh TJ
Endocrinol Metab (Seoul); 2016 Mar; 31(1):45-51. PubMed ID: 26996422
[TBL] [Abstract][Full Text] [Related]
80. Gut microorganisms as promising targets for the management of type 2 diabetes.
Delzenne NM; Cani PD; Everard A; Neyrinck AM; Bindels LB
Diabetologia; 2015 Oct; 58(10):2206-17. PubMed ID: 26224102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
